| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |